The Annexure

News to 9 October 2026 ·

What the ground filed.

A desk of BSE disclosures — every listed company, sliced the way you need it.

Data as of 9 October 2026

Order / Contract

Award_of_Order_Receipt_of_Order

Disclosure under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 - Regulatory Order(s)

The filing

Disclosure under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 - Regulatory Order(s)

Company
Emcure Pharmaceuticals Ltd · BSE 544210
Filed
2 October 2026, 21:29 IST
BSE category
Company Update / Award of Order / Receipt of Order
Tag
Order / Contract · selected
Source
Open the filing on BSE →

Why it led

  • First Order / Contract from this company — not seen in the 93 trading days on record
  • Mid cap · NIFTY 500

Selected by the ranker from 15 filings that day. Each line above is a component of that score, not a comment on the filing.

How often this tag appears

680 of 90,553 filings in the published window carry Order / Contract · 0.75%

Around it

Most recent filings from Emcure Pharmaceuticals Ltd

The company

Emcure Pharmaceuticals Ltd

BSE 544210 · NSE EMCURE · ISIN INE168P01015 · Group A · Active

Healthcare › Healthcare › Pharmaceuticals & Biotechnology › Pharmaceuticals

Full figures, price and filing history for Emcure Pharmaceuticals Ltd →